Adalimumab

Details

Files

Generic Name:

Adalimumab

Project Status:

Complete

Therapeutic Area:

Psoriasis

Manufacturer:

Abbott Laboratories, Limited

Brand Name:

Humira

Project Line:

Reimbursement Review

Project Number:

SR0130-000

Submission Type:

Initial

Indications:

Psoriasis

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

October 16, 2008

Files

Recommendation and Reasons: Updated View PDF

Submission Status Report View PDF

Recommendation and Reasons: Original View PDF

Last Updated : April 15, 2008